A phase II study of gemcitabine combination with TS-1 [S-1] in patient with advanced or recurred pancreatic cancer
Phase of Trial: Phase II
Latest Information Update: 31 Oct 2007
At a glance
- Drugs Gemcitabine (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 31 Oct 2007 Status changed from recruiting to completed.
- 21 Mar 2007 New trial record.